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ABSTRACT  
Oversizing of the Nitinol stents in the femoro-popliteal arterial tract is commonly performed 
by clinicians and further encouraged by stent manufacturers. However, in spite of the 
procedure’s supposed benefits of strong wall apposition and increased luminal gain, its 
effects on the mechanical behavior of arteries with peripheral arterial disease are not fully 
clear. In this study, finite element analyses of endovascular revascularization of an idealized 
artery with 70% stenosis and three different plaque types have been performed to examine 
the influence of Nitinol stent oversizing on the arterial stresses and acute lumen gain. The 
analyses included the simulation of balloon angioplasty to model plaque failure, followed by 
stent implantation, in which four different oversizing ratios were investigated. Results 
showed that balloon angioplasty was crucial in determining the stress levels of the artery 
prior to stent implantation and heavily affected the outcome of endovascular therapy. For all 
plaque types, Nitinol stent oversizing was found to produce a marginal lumen gain in 
contrast to a significant increase in arterial stresses. For the arteries with lightly and 
moderately calcified plaques, oversizing was found to be non-critical; whereas for the 
arteries with heavily calcified plaques, the procedure should be avoided due to a risk of 
tissue failure.  
Key words: Femoro-popliteal artery; calcification; finite element analysis (FEA); 
percutaneous transluminal angioplasty (PTA); plaque failure; stent deployment; stent mis-
sizing; lumen gain; arterial stresses 
  
Introduction 
Endovascular treatment of Peripheral Arterial Disease (PAD) is either primarily performed by 
either percutaneous transluminal angioplasty (PTA) or through primary stent implantation 
following revascularization.18,33 In the case of the latter, choosing the correct stent size is 
crucial to simultaneously counteract arterial recoil and prevent extensive damage to the 
arterial tissues.38,47 However, due to a lack of established guidelines, the current clinical 
practice consists of the qualitative selection of the proper stent size based solely on 
recommendations provided by the stent manufacturers. As a result, Nitinol stent oversizing 
is frequently performed to maintain full wall apposition and prevent stent migration.25,36,38,47 
Despite these perceived advantages, the large stresses inflicted onto the arteries due to 
oversizing might lead to arterial damage and, ultimately, to restenosis.8,20,37,45 
The number of studies on Nitinol stent oversizing in the peripheral vasculatory system are 
scarce. To date, there have only been two animal investigations that have studied the 
implications of coated and non-coated Nitinol stent oversizing in Yucatan swine and mini-
pigs.38,47 Both studies have defined over-sized arteries as having a stent-to-artery ratio, i.e. 
the ratio of nominal stent diameter to lumen diameter of the artery, above 1.4 and 
suggested that while all the arteries have shown neointimal proliferation, only the oversized 
arteries (stent-to-artery ratio > 1.4) were damaged enough to exhibit restenosis. However, 
these studies were performed in healthy arteries and, as such, the results might not be 
applicable to the patient population that undergoes endovascular therapy of the lower 
limbs. A clinical study on stenosed carotid arteries supports this hypothesis, as the results 
suggest that oversized arteries (stent-to-artery ratio between 1.4 and 2.0) yield better 
outcomes in terms of late lumen loss compared to normal-sized arteries (stent-to-artery 
ratio below 1.4).36 These contradictory outcomes can be attributed not only to the 
differences in the vasculature systems, but also to the different morphologies and mechanics 
between healthy and diseased arterial layers. Therefore, to understand the effects of Nitinol 
stent oversizing on the actual clinical practice, the procedure should be evaluated on 
peripheral arteries with PAD. 
Numerical analyses are routinely used to support or replace experiments with the intention 
to analyze the fatigue life of stents.15,29,30,34 They are also frequently used to understand the 
mechanical and hemodynamic behaviors of both healthy and diseased arteries due to stent 
implantation.3,8,17,24 In this instance, the numerical approach is a suitable substitute to 
performing clinical investigations that would be ethically questionable due to a high risk of 
damage to both the plaque and healthy arterial tissues. The majority of the previous 
numerical studies on stent mis-sizing have focused on balloon-expandable stents in coronary 
arteries.4,5,23,26 These studies have shown that stent implantation tends to disrupt the 
natural flow patterns and that oversizing (stent-to-artery ratio > 1.0) negatively impacts the 
Wall Shear Stress (WSS) and, consequently, increases the risk of restenosis. However, the 
results are not directly adaptable either to the endovascular procedures performed in lower-
limbs or to the common clinical practice due to the differences in stent types, their 
deployment techniques and the use of healthy arterial models. On the other hand, the 
limited number of studies that cover Nitinol stent oversizing in peripheral arteries performed 
the analyses on non-calcified arteries.17 As such, the effects of Nitinol stent oversizing on the 
mechanical behavior of arteries with calcified plaques are currently not known. Therefore, 
the main aim of this study was to investigate the changes in arterial stresses and acute 
lumen gains associated with gradual stent oversizing. The numerical investigation was 
performed using finite element (FE) analyses of endovascular therapy in an artery model 
that included clinically relevant PAD. A secondary objective was to observe whether the 
effects of oversizing were influenced by the degree of lesion calcification. 
  
Materials and Methods 
Components of the FE Simulations 
Five parts were required for the FE modeling of the endovascular therapy; the diseased 
artery, the angioplasty balloon/s, the Nitinol stent, and the expansion and crimp tools. The 
artery was idealized as a straight cylinder with completely healthy sections at both ends and 
a mix of healthy and atherosclerotic tissue at the center for a total length of 35 mm (Fig. 1). 
Each healthy section had a length and lumen diameter of 5.0 mm44 and were made of 3 
layers24; intima, media and adventita with thicknesses of 0.15 mm, 0.25 mm and 0.1 mm, 
respectively.40,41 The diseased section was created by increasing the thickness of the intimal 
layer to reach a luminal diameter that corresponded to 30% of the healthy lumen, which is 
indicative of a clinically relevant PAD. Since a 50% obstruction in the lumen diameter of a 
peripheral artery is considered as stenosis or in-stent restenosis and a 100% blockage is 
defined as a total case of occlusion1,46, the 70% obstruction chosen for this study is between 
these two extremes and indicative of a clinically relevant PAD. By modifying the mechanical 
tissue properties of the thickened intimal layer to represent an atherosclerotic plaque, the 
stenosed tissue had been directly embedded into the artery. This approach enabled a 
geometrically smooth transition between the healthy and diseased sections and the 
resultant configuration corresponded to a symmetric plaque (Fig. 1a). As it was previously 
shown that femoral plaques are typically heavily calcified10,12,14,19,27, the plaque only included 
calcification and not any underlying sections of lipid pool or fibrotic tissues. The plaque was 
modeled as a single geometrical entity; as such, the fibrotic tissue, the lipid pool and the 
calcification were not modeled separately. Instead, the plaque represented a mixture of 
calcified and non-calcified tissues through its mechanical properties. Each layer, including 
the plaque, was discretized with linear hexahedral reduced integration elements (C3D8R). In 
each healthy section, the number of elements in intima, media and adventitia were 
approximately 4,000, 7,000 and 4,000, respectively. For the diseased section, the number of 
elements in the medial and adventitial layers were increased by approximately 2 times their 
healthy counterparts, while the plaque was meshed with approximately 50,000 elements. A 
mesh sensitivity analysis was performed to verify that the mesh was sufficiently dense to 
satisfy the convergence criteria defined in a previous study.17 
The initial geometry of the angioplasty balloon corresponded to its fully-expanded 
configuration with a diameter of 5.0 mm and a length of 25 mm (Fig. 1b). The balloon had 
4,000 linear quadrilateral membrane elements with reduced integration (M3D4R). A 
commercially available Nitinol stent, Astron-Pulsar (Biotronik AG, Bülach, Switzerland), with 
production dimensions of 80µm strut width, 155µm strut thickness, 3.5 mm outer diameter 
and 25 mm length was considered for the simulations (Fig. 1d). These dimensions 
represented the configuration right after the stent was laser-cut from a Nitinol tube and 
before the in-silico expansion and annealing. The number and type of elements for the stent 
were previously verified and corresponded to 170,000 linear reduced integration elements 
(C3D8R).17 The rigid expansion and crimp tools, which were used for the preconditioning and 
deployment of the stent, were both meshed with linear quadrilateral shell elements with 
reduced integration (S4R). The expansion tool had the same initial diameter as the inner 
diameter of the stent. Conversely, the diameter of the crimp tool corresponded to the 
unconstrained stent diameter achieved at the end of the preconditioning state and, as such, 
varied with each oversizing case (Fig. 1d).  
 
Constitutive Models 
The healthy arterial layers were represented with the Holzapfel-Gasser-Ogden (HGO) model; 
an anisotropic, hyper-elastic material model that includes two collagen fibre families.16,21 
The material parameters were obtained from uniaxial tensile tests performed on the healthy 
portions of a single diseased external iliac artery acquired from autopsy. The exact values, 
including the fibre orientations and fibre dispersions within each layer, have been reported 
previously.17,21  
The atherosclerotic tissue was modeled as isotropic, hyper-elastic using a 3rd order reduced 
polynomial form (Yeoh) based on the uniaxial planar tension experiments experimental data 
performed on 20 samples of human atherosclerotic femoral plaques (Table 1).11 The fitting 
was performed in Abaqus v.6.12 (Dassault Systemes, Simulia Corp., RI, USA) by providing the 
experimental data as the input for the material model. It was previously shown that femoral 
plaques are typically heavily calcified.10,12,14,19,27 However, in order to cover the entirety of 
the experimental data, three plaque groups (lightly calcified, moderately calcified and 
heavily calcified) were considered for the analyses. The experiments experimental data 
showed that the lightly calcified plaque underwent high stretch until tissue failure (0.3 MPa 
at a nominal strain of 1.15); while the moderately calcified plaque reached a higher ultimate 
tensile stress (0.43 MPa) at a nominal strain of 0.75. This suggests shows that the 
moderately calcified plaque was stiffer compared to the lightly calcified plaque. On the other 
hand, both the ultimate tensile stress and stretch values for the heavily calcified plaque were 
lower than the other plaque types (0.16 Mpa at a nominal strain of 0.55). This behavior has 
been associated with the unique morphology of the heavily calcified plaque, which differs 
not only from the other femoral plaques, but also from the heavily calcified plaques from 
other anatomical regions.32 However, as As a result of its low failure stress and strain, the 
elastic mechanical response of the heavily calcified plaque prior to failure was very similar to 
the lightly calcified plaque.  
Similar to previous studies that modeled plaque failure during endovascular therapy, a 
perfect plasticity model was adopted to represent tissue damage.6,8,9,15,35 This method allows 
the plaque to undergo plastic deformation, while preventing an increase in its stresses. Once 
the plastic limit is reached, the loads exerted onto the artery are transferred to the healthy 
layers. Upon unloading, the plaque is plastically deformed and the lumen diameter is 
permanently increased. At that point, the stresses in the healthy layers are determined by 
the extent of plastic deformation in the atherosclerotic tissues. The plasticity thresholds in 
this current study corresponded to the failure stress levels of each plaque group (Fig. 2).11,13 
A justification for using failure stresses as yield stresses in the perfect plasticity model is 
provided in the discussion. 
The angioplasty balloon was modeled with a linear, elastic material model. The material 
parameters, as well as a mass proportional Rayleigh damping coefficient, which was assigned 
to make the folding and inflation of the balloon more stable, were taken from literature.8 
The material parameters for the super-elastic Nitinol model were provided by the 
manufacturer.17 Finally, the rigid crimp and expansion tools were represented with a linear, 
elastic model (Young’s modulus E: 210,000 MPa; Poisson’s ratio ν: 0.3). 
Simulations of the Endovascular Therapy  
The simulations were performed using Abaqus/Explicit with a user-defined, semi-automatic 
stable time increment of 4 x 10-6. This value ensured that the kinetic energies of each 
individual part and the whole assembly remained below 5% of their corresponding internal 
energies at any given time during the analyses. As a result, the quasi-static nature of the 
analyses was preserved at all time points of the simulations. A symmetry boundary condition 
was defined at the middle of the angioplasty balloon to prevent it from moving axially during 
the folding/unfolding steps. Finally, the artery was constrained at both ends to prevent 
movement in the longitudinal axis. A hard, frictionless contact was defined for the 
interactions between the balloon and the artery, as well as between the stent and the 
artery, using the general contact algorithm. On the other hand, the interactions between the 
tools and the stent were established with a surface-to-surface contact methodology, which 
ensured a proper separation of the surfaces. 
Prior to the main analysis of endovascular therapy and stent oversizing, the initial 
configurations of the stent, the balloon and the artery were prepared through three 
standalone simulations. The first one was stent preconditioning, which consisted of an initial 
expansion of the stent to its unconstrained, i.e. nominal, diameter, followed by an annealing 
procedure that was performed to remove the stresses and preserve the expanded shape. A 
total of four oversizing ratios, 1.0, 1.2, 1.4, and 1.8, were investigated in this study. The 
unconstrained stent diameter for each case was calculated by multiplying these ratios with 
the healthy lumen diameter (i.e. 5 mm, 6 mm, 7 mm and 9 mm). For this simulation, the 
contact interaction between the outer surface of the expansion tool and the inner surface of 
the stent was activated. Subsequently, the stent was expanded by applying velocity 
boundary conditions to the nodes of the expansion tool. The second simulation was the 
folding of the angioplasty balloon by applying a negative pressure to the balloon’s inner 
surface. The third and final simulation was an iterative process to determine the stress-free 
diameter of the artery, such that the healthy lumen diameter corresponded to the average 
diameter of the popliteal artery (i.e. 5 mm) under the physiological blood pressure of 120 
mmHg.42 The deformed, stress-free configurations of the stent, the balloon and the artery 
were, then, brought together in a new assembly for the main analysis. In addition to these 
preparation simulations, the changes in the radial force profile of the stent with respect to 
different oversizing ratios were evaluated through further analyses, where the stents were 
crimped to their insertion diameter of 1.2 mm and expanded back to their unconstrained 
diameters. 
The main analysis included the clinical processes of balloon angioplasty and stent 
implantation (Fig. 1). In the first step, the artery was pressurized by applying the 
physiological blood pressure of 120 mmHg on the inner surface of the artery (Fig. 1a). Next, 
the contact pair of balloon-artery was activated, and balloon angioplasty was simulated by 
applying a positive pressure of 7 atm. to the inner surface of the balloon (Fig. 1b). 
Subsequently, the balloon was folded and the minimum lumen diameter was checked to 
evaluate the success of the angioplasty (Fig. 1c). If the lumen diameter was below 70% of the 
healthy lumen diameter,15 then an additional angioplasty was performed using a larger 
balloon diameter. Following the adequate expansion of the lumen, the contact interaction 
between the inner surface of the crimp tool and the outer surface of the stent was activated 
and the stent was crimped to its insertion diameter of 1.2 mm by radially displacing each 
node of the crimp tool (Fig. 1e). Finally, the contact pair of stent-artery was activated and 
the stent was expanded by radially expanding the crimp tool to its original position. As the 
stent came into contact with the artery, it detached from the crimp tool and was deployed 
into the artery (Fig. 1f).  
Data Analysis 
The effects of Nitinol stent oversizing were evaluated by analyzing the stress distribution (in 
particular, the 95th percentile) along the circumferential direction in the healthy layers 
surrounding the diseased region and the minimum lumen diameter at the end of 
pressurization, after balloon angioplasty and post stent deployment. 
It is hypothesized that high arterial stresses possibly lead to adverse outcomes in 
patients.17,45 Since a stress threshold that puts the artery at risk is unknown, previous studies 
have investigated the effects of stent implantation based on tissue failure8,9, which could be 
corroborated by experimental findings. Similarly, in this study, the 95th percentile stresses 
calculated with the numerical model were compared to the ultimate experimental stresses 
in the circumferential directions for the healthy layers surrounding the atherosclerotic 
tissue.16 The arterial layer identified as the most failure-prone was analyzed to establish the 
effects of endovascular therapy and Nitinol stent oversizing.  
For the calculation of the minimum lumen diameter, the position of each node at the arterial 
lumen interface was extracted from Abaqus and exported to Matlab. Along the length of the 
artery, circles were fitted to each of the 108 rings of nodes representing the arterial lumen. 
The diameters of the circles corresponded to the lumen diameters along the length of the 
artery and the smallest one was reported as the minimum lumen diameter. 
Additionally, the equivalent plastic strain (PEEQ) distributions, as well as the 95th percentile 
PEEQ values at the integration points, in the atherosclerotic tissue tissues were reported to 
quantify plaque failure among the 3 different plaque types.  
  
Results 
The complete radial force profile of the stent clearly showed the super-elastic behavior of 
the Nitinol material,43 where the stent’s outward force remained near-constant across a 
wide range of diameters during crimping and deployment into the artery (Fig. 3). Increasing 
the oversizing ratio resulted in a higher radial force to be applied by the stent onto the 
artery during deployment. This difference was highest between the unconstrained stent 
diameters of 5 and 6 mm, which exhibited a 40% increase in the stent’s radial force. The 
difference in the radial force was smaller – approx. 20% - when the unconstrained stent 
diameter increased from 7 to 9 mm. In contrast, the change in stent’s radial force is was 
nominal (approx. 5%) between the unconstrained stent diameters of 6 and 7 mm.   
Under the physiological blood pressure of 120 mmHg, the circumferential stresses in the 
healthy layers surrounding the diseased region, as well as the minimum lumen diameters, 
were comparable between the different plaque groups (Table 2). This suggested that all the 
artery models were in a similar mechanical condition prior to balloon angioplasty. The initial 
PTA with a 5 mm angioplasty balloon yielded different outcomes for the three plaque types. 
The minimum lumen diameters for the vessels with lightly, moderately and heavily calcified 
plaques were 2.5 mm, 3.2 mm and 3.4 mm, respectively (Table 3). At this stage, only the 
vessel with heavily calcified plaque satisfied the requirement to continue with stent 
implantation, as it was the only arterial model that reached a diseased lumen diameter 
corresponding to 70% of the healthy lumen diameter.15 This can be explained by the low 
stress-strain threshold (0.16 MPa at a nominal strain of 0.55) required to start the plastic 
deformation process in the heavily calcified plaque. As a result, the heavily calcified plaque 
underwent greater plastic deformation than both the moderately and lightly calcified 
plaques, which reached their constant stress thresholds at considerably higher strain values 
of 0.75 and 1.15, respectively (Fig. 2). 
To satisfy the deployment criteria, the arteries with lightly and moderately calcified plaques 
underwent a second PTA. The additional PTA of the artery with moderately calcified plaque 
using a 5.5 mm balloon yielded a lumen diameter of 3.5 mm. On the other hand, even with a 
6 mm balloon, only a 3.0 mm lumen diameter could be reached for the artery with lightly 
calcified plaque, resulting in a partially successful balloon angioplasty. This can be attributed 
to the high amounts of stretch required to plastically deform the lightly calcified plaque. The 
PEEQ distributions in the atherosclerotic tissues following PTA support these observations 
(Fig. 4). Among the different plaque types, the heavily calcified plaque had the highest 
plastic strain not only at the lumen interface, but also along the thickness of the plaque after 
the initial balloon angioplasty (Fig. 4c). In line with the achieved lumen gains diameters, the 
lightly calcified plaque exhibited the least amount of plastic strain within the complete 
atherosclerotic tissue (Fig. 4a), while the plastic strain in the moderately calcified plaque 
were was in between the two groups (Fig. 4b). The 95th percentile PEEQ strain values after 
the 1st PTA for the lightly, moderately and heavily calcified plaques were 1.02, 1.33 and 
1.42, respectively. A 2nd PTA significantly affected the plastic strain distribution in the 
moderately calcified plaque. The procedure increased the overall plastic strain level (the 
95th percentile PEEQ strain = 1.41) and led to an increase in the volume that underwent 
plastic deformation (Fig. 4e). The final state slightly exceeded the distribution observed in 
the heavily calcified plaque after one PTA (Fig. 4c). Performing a 2nd PTA also had a similar 
effect on the distribution of plastic strain in the lightly calcified plaque (Fig. 4d). However, 
the overall plastic strain was still lower than the other plaque groups (the 95th percentile 
PEEQ strain = 1.33). 
Following PTA, the arteries with heavily and moderately calcified plaques were in high stress 
states (Table 2). Additionally, they had similar stress values in the healthy layers surrounding 
the plaque. These can be attributed to the high levels of plastic strain observed in both 
plaque types. Comparatively, the stresses in the artery with lightly calcified plaque were 
significantly lower as its atherosclerotic tissue underwent a smaller plastic deformation than 
the other plaque types.  
The implantation of a Nitinol stent further increased the stresses and lumen diameters in all 
the artery models (Tables 2 & 3). However, compared to PTA, the procedure did not cause 
any additional plastic deformation. As a result, the outcome of the stenting procedure is 
directly influenced by the hyperelastic behavior, i.e. the mechanical stiffness, of the plaque, 
since the plaque tissue continued to support the loads exerted onto the artery following 
PTA. 
Regardless of the oversizing ratio and the plaque type, the 95th percentile circumferential 
stresses in the media following Nitinol stent implantation was found to be approximately 60 
kPa. As such, the stresses in the medial layer only reached up to 15% of the tissue’s ultimate 
tensile stress of 420 kPa.16 In comparison, even in the model with the lowest stresses in the 
adventitia, the values reached up to 30% of the failure stress of 1,300 kPa. Based on the 
stress levels this observation, the most failure-prone healthy layer was found to be the 
adventitia. Figure 5 shows the stress distribution of the artery with moderately calcified 
plaque following Nitinol stent implantation with different oversizing ratios. Regardless of the 
oversizing ratio, the artery with heavily calcified plaque always had the highest 
circumferential stresses and lumen diameter (Fig. 6). This can be attributed to the high 
stress-state of the artery following PTA and the low stiffness of the plaque (Fig. 2). On the 
other hand, while the lightly calcified plaque had a similar stiffness as the heavily calcified 
plaque, the artery always had the lowest circumferential stresses and lumen diameter. This 
low level of stress directly results from the low stress-state following balloon angioplasty. 
Stent implantation has led to a narrow distribution of the stresses in the arteries with lightly 
and moderately heavily calcified plaques (Fig. 6). Again, this can be attributed to the low 
stiffness of the plaque tissues, allowing a uniform deformation and stress increase along the 
entire tissue. In contrast, the stress distribution in the artery with moderately calcified 
plaques was much wider, with lower minimum values than the stress levels observed in the 
arteries with lightly calcified plaques. This can be explained by the higher stiffness of the 
moderate plaque, acting as a stronger barrier that limits the amount of load transferred to 
the healthy tissues.  
For all plaque groups, increasing the oversizing ratio led to a linear increase in the 
circumferential stresses (Fig. 7). Similarly, a linear relationship was observed between the 
oversizing ratio and the lumen diameter (Fig. 7). The artery with heavily calcified plaque, 
followed by the artery with lightly calcified plaque, exhibited the largest increase in arterial 
stresses with increased oversizing. Correspondingly, these two plaque types had the largest 
increases in the acute lumen gains with oversizing. The similar behavior between these two 
arterial models can be attributed to the similar stiffness of the lightly and heavily calcified 
plaques (Fig. 2). In comparison, the artery with moderately calcified plaque was the least 
affected in terms of arterial stresses and lumen gain due to the high stiffness of its plaque.  
  
Discussion 
Nitinol stent oversizing is a term used to describe the ratio and, in extreme cases, the 
mismatch between healthy lumen and stent diameters.38,47 The procedure can occur either 
on purpose, by selecting a stent diameter that is larger than the healthy lumen diameter, or 
inadvertently, by implanting a single long stent over a considerably long lesion (>300 mm), 
which results in a mismatch between the constant stent diameter and the narrowing 
lumen.7,25 Currently, stent manufacturers provide a stent-specific value as the recommended 
oversizing ratio. However, the bases for selecting these values are unclear. With no objective 
guidelines, clinicians either avoid oversizing and, as a result, do not utilize the procedure’s 
possible advantages (i.e. preventing stent migration, achieving a desirable lumen gain 
immediately after implantation etc.),36 or they tend to oversize the stents and risk arterial 
damage. More recently, animal studies and numerical analyses have been conducted to 
define an ideal oversizing ratio for the peripheral arteries.38,47 However, they were limited by 
the use of healthy arteries, whose morphologies are considerably different than diseased 
arteries. Thus, to understand the real-world implications of Nitinol stent oversizing, these 
studies should primarily be conducted on diseased arteries. Therefore, the aim of this study 
was to investigate the effects of Nitinol stent oversizing on the mechanical behavior of 
peripheral arteries by performing in-silico analyses of endovascular therapy in arterial 
models with a clinically relevant model of PAD. Furthermore, three different plaque types 
were considered in the model to evaluate whether the severity of plaque calcification has 
any influence on the treatment outcomes.  
The mechanical behavior of the artery during PTA is strongly affected by the plaque type. At 
this point of the procedure, the stiffness of the plaque had little influence on the final 
configurations of the dilated arteries. Instead, both the arterial stresses and lumen gain were 
directly defined by the strain values that corresponded to the start of plastic deformation in 
the plaque tissues (Table 1).13 Between the lightly and moderately calcified plaques, the 
former had to undergo a comparatively higher stretch to reach its plastic limit (Fig. 2). On 
the other hand, the stress and strain values associated with the plasticity threshold of the 
heavily calcified artery was considerably lower than the other plaque types. These strain 
values (Table 1)13 directly defined the configurations of the arteries following PTA. Thus, two 
of the artery types required a 2nd balloon angioplasty to achieve a satisfactory lumen 
diameter due to the high stretching that was necessary to start plastic deformation in their 
plaques. A 2nd PTA increased the amount of plastic strain in the moderately calcified plaque 
(Fig. 4d) to similar levels observed in the heavily calcified plaque after one PTA (Fig. 4c). This 
meant that both plaque types experienced similar amounts of plastic deformation, which 
can also be inferred from the similar lumen diameters and arterial stresses between the two 
artery types (Tables 2 & 3). For the lighly calcified artery, even a second PTA was insufficient 
to reach the level of strain needed to undergo the same level of plastic deformation as the 
other plaque types. As a result, the arteries with moderately and heavily calcified plaques 
were both in a higher stress state compared to the artery with lightly calcified plaque 
following PTA. 
The type of plaque also affected the outcomes following Nitinol stent implantation. In 
contrast to the mechanism behind the final configuration of the arteries following PTA, the 
effects of Nitinol stent implantation were not determined by the plastic stress or strain 
thresholds. Due to the use of perfect plasticity as a damage model Since damage was 
modeled as perfect plasticity, the deformed plaque continued to support the loads exerted 
onto the artery by the stent. However, unlike the situation during PTA, only the hyper-elastic 
behavior of the plaque influenced determined the final configuration of the artery, as no 
additional plastic deformation was observed during stent deployment. As a result, the lumen 
gain obtained following stent implantation was considerably lower than the one gain 
achieved after PTA. At this point of the procedure, the differences and similarities in both 
the stress states and lumen gain between the different plaque types directly resulted from 
the stiffness of the plaques. The artery with heavily calcified plaque had a substantial 
increase in adventitial stresses following stent implantation due to its low mechanical 
stiffness in the elastic region (Table 2). Although being at a comparatively lower stress state 
after PTA, the artery with lightly calcified plaque also had a significant increase, which can be 
attributed to the similar mechanical stiffness of the two plaque types (Fig. 2). On the other 
hand, the artery with moderately calcified plaque had the least increase in adventitial 
stresses with stent implantation due to the higher stiffness of the moderate plaque. In that 
sense, the presence of a moderately calcified plaque would decrease the risk of arterial 
damage by limiting the stress increase in the healthy arterial layers. These outcomes were 
accordingly reflected in the lumen gain diameters observed following stent deployment, 
with the arteries with heavily and lightly calcified plaques achieving a similar and higher 
lumen gain compared to the artery with moderately calcified plaque (Table 3) (Fig. 7).  
For all plaque types, the increases in adventitial stresses and acute lumen gains with respect 
to Nitinol stent oversizing were heavily dependent on the stent’s radial force profiles for 
different oversizing ratios (Fig. 3). A larger increase in the radial force of the stent has led to 
a correspondingly large increase in both arterial stresses and lumen diameters. As such, 
increasing the oversizing ratio from 1.0 to 1.2 (5 mm to 6 mm) or from 1.4 to 1.8 (7 mm to 9 
mm) had a bigger effect on the mechanical response of the artery compared to the similar 
outcomes obtained with increasing the ratio from 1.2 to 1.4 (6 mm to 7 mm) (Tables 2 & 3). 
Despite this, the relationship between the arterial stresses (the 95th percentile, the 75th 
percentile and the median values) and the oversizing ratio, as well as the relation between 
the acute lumen gains and the unconstrained stent diameters, was found to be well 
approximated with a linear function for all plaque groups (Figs. 6 &7). However, a mismatch 
between the increases in arterial stresses and lumen gain was also present with oversizing 
(i.e. 31% stress increase vs. 4% increase in the lumen gain when the oversizing ratio was 
increased from 1.0 to 1.8 for the artery with lightly calcified plaque).  
Comparison of the results with an oversizing study conducted in healthy peripheral arteries 
showed that the outcomes of the procedure differed significantly between the two artery 
types.17 Oversizing of healthy arteries led to nonlinear increases in both arterial stresses and 
lumen gains (Fig. 7). Furthermore, regardless of the plaque type, diseased arteries were less 
sensitive to oversizing, showcased by a smaller increase in adventitial stresses between each 
oversizing ratio. This can be explained by the difference in the distribution of the loads 
between the healthy and diseased arteries. Whereas the adventitia primarily supported the 
majority of the mechanical load in the healthy artery;, in the diseased arteries, the load was 
distributed between the plastically deformed plaque and the adventitia. This suggests that 
the plaque tissue acts as a protective layer between the stent and the healthy layers by 
preventing a critical increase in arterial stresses. 
Following stent implantation, the arteries with moderately and heavily calcified plaques 
exhibited higher stresses compared to the healthy artery. This result can be attributed to the 
revascularization of the artery with PTA. This procedure was only performed in the diseased 
arteries and determined the arterial stresses prior to stent deployment. By comparison, the 
stress levels in the arteries with moderately and heavily calcivited calcified plaques after PTA 
corresponded to the stresses calculated in the healthy artery with an oversized stent of 5.5 
mm. At this stage, deploying a stent in the arteries with moderately and heavily calcified 
plaques further increased their high stress levels and ensured that their final stress states 
would be higher than the healthy artery. On the other hand, the artery with lightly calcified 
plaque was at a low stress state after PTA and the additional stresses produced by stents did 
not exceed the stress levels in the healthy arteries.  
In terms of lumen gain, the results previous numerical and experimental studies suggested 
that the adventitia acted acts as a protective layer and prevented prevents the artery from 
significant expansion in healthy arteries.16,17,22 In the diseased arteries, however, the stent 
continued to push against the plaque, without producing any additional plastic deformation. 
As such, the resultant lumen gain was determined by the stiffness of the plaque tissue. Since 
the arteries with lightly and heavily calcified arteries had a low mechanical stiffness, they 
produced a higher lumen gains than the non-calcified arteries. Despite these differences, the 
mismatch between the low lumen gain induced by stent oversizing and the large increase of 
the arterial stresses was also observed for the healthy arteries. 
Several assumptions had to be made within the current numerical framework. Within the 
diseased region, the intimal layer was replaced with the plaque tissue. However, since the 
adventitia becomes the mechanically predominant layer under high pressures (following 
PTA),22,31,39 the influence of the intimal layer on the mechanical behavior of the artery would 
be small and can be neglected. The artery was not pre-stressed, which may decrease the 
final values of the stresses observed after stent implantation. However, arterial pre-stressing 
would not affect the linear relation between the oversizing ratio and either the stresses or 
the lumen gain.  
Concerning the experimental data adopted for this study, it should be noted that the 
mechanical behavior of the heavily calcified plaque seems counter-intuitive. Its failure stress 
and strain are lower than the other plaque types and its stiffness is very similar to the lightly 
calcified plaque. The authors of the data explained that this behavior is associated with this 
plaque’s unique morphology, which is different from other plaque types.11 Further 
explanations can be derived from a recent experimental study performed on the carotid 
plaque tissues, which exhibited a similar mechanical behavior as the femoral plaques.2 
Through ex-vivo computer tomography (CT) imaging, the carotid samples were characterized 
as a mixture of calcified and non-calcified tissues. The calcification was suggested to act as a 
mechanical restraint to the applied loading. As such, the plaque deformation was only 
restricted to the stretching of the non-calcified tissue. This explains the reduced failure 
stretch with increasing calcification, as the remaining tissue available for stretching is 
decreased. On the other hand, the increased plaque strength has been postulated to be 
caused by a strong adhesion between the calcified and non-calcified tissues that compose 
the samples. Although this recent study brings new insights to the experimental data used in 
the current numerical models, additional experiments on the femoral tissues are needed to 
confirm these observations. 
The model of perfect plasticity that is used for reconfiguring the plaque tissue represents a 
simplified approach to the failure of the calcified plaque. Although not exactly a failure 
model, perfect plasticity is commonly used to model plaque failure during endovacular 
therapy.6,8,9,15,35 The majority of these studies have set the stress threshold at 400 kPa6,8,9, 
which corresponded to an average value of plaque failure under uniaxial tensile tests.28 The 
remaining studies have used 270 kPa, which represented the rupture stress of a single 
atheresclerotic plaque.15,35 Conway et al. have justified using the ultimate tensile stresses as 
the plastic stress threshold by conducting a parametric study with different values.9 Their 
results showed that the variances in the stress threshold had a marginal effect on the 
mechanical behavior of the artery; changing the yield stress from 200 kPa to 400 kPa 
resulted in less than a 5% change in vessel recoil for all plaque types. Recently, Chiastra et al. 
have used the same methodology to simulate PTA and stent implantation in numerical 
models of coronary bifurcation.6 A combination of CT angiography and Optical Coherence 
Tomography (OCT) was used to validate the simulations. The results showed approximately 
15%-20% error between the calculated shape of the artery and the experimental 
reconstruction based on the Hybrid OC-CT methodology. The results from both of these 
studies suggested that using failure stresses as a plastic threshold is a suitable approximation 
to model plaque failure.  
In any case, there is no information in the literature that suggests the plaque actually 
behaves the way it is modeled in this study during balloon angioplasty. Furthermore, with 
this model, the deformed plaque continues to support the loads that are exerted onto the 
artery by the stent, which may lead to an underestimation of the arterial stresses. 
Experimental and clinical studies that focus on understanding the failure behavior of the 
plaque should be undertaken to improve the existing knowledge and modeling of the failure 
characteristics of the atherosclerotic tissues. Finally, the results provide an overview of 
Nitinol stent oversizing based on a single stent design. Although we believe that the general 
behavior would be similar for other designs, the actual stress values and lumen diameters 
would likely be different. 
  
Conclusion  
Despite Nitinol stent oversizing being routinely performed during endovascular 
interventions, the number of experimental and numerical studies that investigate the effects 
of the procedure has been limited. Furthermore, the studies have been performed almost 
exclusively on healthy arterial models and completely overlooked the plaque tissue, the 
procedure of balloon angioplasty and the effect of the reconfigured calcified plaque on the 
outcomes of stent deployment. Therefore, this study used arterial models with calcified 
plaques in order to give some insights on the implications of Nitinol stent oversizing in 
patients undergoing endovascular revascularizations. PTA was the primary force behind 
achieving a substantial lumen gain and the procedure significantly contributed to the final 
stress state of the artery. As Nitinol stent implantation did not cause any additional plastic 
deformation, the mechanical stiffness of the plaques determined the additional lumen gain 
and arterial stresses produced following stent deployment. Compared to the healthy 
arteries, the plaque tissues present in the diseased arteries acted as a protective barrier 
during stent implantation by limiting the amount of stresses transmitted to the healthy 
arterial layers. Among the different plaque types, oversizing seems not to be critical for the 
arteries with lightly and moderately calcified plaques; the former being at a lower stress 
state after PTA (due to the high strain level required to induce plastic deformations) and the 
latter having the least increase in adventitial stresses with oversizing (due to the stiff plaque 
behavior). However, for both cases, the procedure only produced a marginal lumen gain. For 
the arteries with heavily calcified plaques, oversizing should be avoided as the low stiffness 
of the plaque led to an increase of an already high stress state achieved following PTA (due 
to the low plasticity threshold) towards the failure limit of adventitia.21 These results further 
support the notion that Nitinol stents are inherently made to act as scaffolds and not as 
instruments to facilitate additional lumen expansion. 
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-  C10 (MPa) C20 (MPa) C30 (MPa) Plasticity Threshold 
Calcification    Stress (MPa) Strain 
Light 5.9 10-2 4.4 10-3 -2.7 10-4 3.0 10-1 1.15 
Moderate 1.4 10-1 3.1 10-2 -1.6 10-2 4.3 10-1 0.75 
Heavy 4.7 10-2 1.5 10-2 -1.3 10-2 1.2 10-1 0.55 
Table 1: Material parameters (C10, C20 and C30) of the Yeoh SEF model for the arteries with 
lightly, moderately and heavily calcified plaques represent the average mechanical behavior 
of the plaque tissue under uniaxial extension planar tension tests11,13. The plasticity 
threshold corresponds to the failure stress of the tissues. 
 
  
 
 
Circumferential Stresses (kPa) (95th Percentile) 
Pre-Angio 
(@ 120 mmHg) 
Post 1st Balloon 
Angioplasty 
Post 2nd Balloon 
Angioplasty 
Post Stent Implantation 
Unconstrained Stent Diameter 
5 mm 6 mm 7 mm 9 mm 
Calcification        
Light 0.6 32 140 371 458 485 543 
Moderate 0.1 161 356 559 590 600 641 
Heavy 0.8 303 - 732 833 851 922 
Table 2: The circumferential stresses (95th percentile) in the adventitial layer following the pressurization of the artery with a physiological 
blood pressure of 120 mmHg (Pre-Angio), balloon angioplasty and stent implantation for the arteries with lightly, moderately and heavily 
calcified plaques. 
 
 
 
 
 
 
 
 
 Minimum Lumen Diameter (mm) 
Pre-Angio 
(@ 120 mmHg) 
Post 1st Balloon 
Angioplasty 
Post 2nd Balloon 
Angioplasty 
Post Stent Implantation 
Unconstrained Stent Diameter 
5 mm 6 mm 7 mm 9 mm 
Calcification        
Light 1.46 2.51 2.98 3.45 3.50 3.51 3.57 
Moderate 1.39 3.16 3.49 3.68 3.71 3.71 3.74 
Heavy 1.48 3.44 - 3.83 3.89 3.90 3.95 
Table 3: The minimum lumen diameter following the pressurization of the artery with a physiological blood pressure of 120 mmHg (Pre-Angio), 
balloon angioplasty and stent implantation for the arteries with lightly, moderately and heavily calcified plaques. 
 
Figure Captions 
Figure 1: The complete procedure of an endovascular therapy in an artery with a clinically 
relevant level of PAD (70% stenosis): The pressurization of the artery with the physiological 
blood pressure of 120 mmHg and the positioning of the angioplasty balloon (a), unfolding of 
the angioplasty balloon with a pressure of 7 atm to simulate plaque failure (b), folding of the 
angioplasty balloon and evaluation of the expanded lumen diameter (c), representation of 
the Nitinol stent and the crimp tool in their unconstrained diameters prior to crimping of the 
stent (d), crimping of the Nitinol stent to a crimp diameter of 1.2 mm to simulate insertion 
into the artery (e), and the deployment of the stent into the artery (f). 
Figure 2: The average stress-strain behaviors of the lightly (n=3), moderately (n=5) and 
heavily (n=12) calcified femoral plaque types under uniaxial tensile planar tension tests show 
that the moderately calcified plaque have the highest stiffness; while the lightly and heavily 
calcified plaque types have similar mechanical behaviors prior to tissue failure.11 The tissue 
damage was modeled using perfect plasticity with the heavily calcified plaque reaching its 
constant stress threshold the earliest (160 kPa at a nominal strain of 0.55) and the lightly 
calcified plaque reaching it the latest (300 kPa at a nominal strain of 1.15) (Table 1).  
Figure 3: The radial force profiles of the Nitinol stent for each of the unconstrained stent 
diameters showed that increasing the oversizing ratio led to an increase in the radial force of 
the stent during crimping and deployment into the artery. As a result, the 9 mm stent 
exerted the highest radial force onto the artery, whereas the 5 mm stent exerted the lowest. 
On the other hand, the difference between the radial forces of the 6 and 7 mm stents during 
deployment was found to be marginal. For visualization purposes, the full radial force profile 
during the crimping and deployment of stent is only shown for the 9 mm stent.   
Figure 4: The PEEQ distributions in the atherosclerotic tissues following the 1st PTA showed 
that the heavily calcified plaque had the largest plastic strain and, as such, the largest plastic 
deformation (c). The extent of plastic deformation was followed by the moderately calcified 
plaque (b) and, finally, the lightly calcified plaque (a). Performing a 2nd PTA resulted in a 
significant increase in the plastic strain level of the moderately calcified plaque (e). On the 
other hand, while the 2nd PTA also increased the extent of plastic deformation experienced 
by the lightly calcified plaque; the overall plastic strain was still lower than the other plaque 
types (d).   
Figure 5: The stress distribution in the artery with moderately calcified plaque following 
stent implantation showed that, regardless of the oversizing ratio, the most failure-prone 
layer was the healthy adventitia over the diseased region. Increasing the oversizing ratio led 
to an increase in the circumferential stresses of the artery, with the 9 mm stent (d) 
producing the highest stress, followed by the 7 mm stent (c), the 6 mm stent (b) and, finally, 
the 5 mm stent (a).    
Figure 6: The stress distribution in the healthy adventitia has been reported for the different 
plaque types and oversizing ratios. Similar to the 95th percentile, the average stresses were 
the lowest lower for the artery with the lightly calcified plaque, followed by and the highest 
for the arteries artery with moderately and heavily calcified plaques. The stress values in the 
adventitia showed a larger scattering for the artery with the moderately calcified plaque 
than for the other types of calcification. The wider distribution can be attributed to the 
plaque stiffness. Despite these differences, there was a linear relationship between the 
unconstrained stent diameters and the circumferential stresses (the 95th percentile, the 
75th percentile, as well as the median values) for all the artery models. 
Figure 7: Regardless of the plaque type, Nitinol stent oversizing resulted in a linear increase 
in both the arterial circumferential stresses (95th percentile) (left) and the lumen gains 
(right). For each oversizing ratio, the highest circumferential stresses were found to be in the 
artery with heavily calcified plaque, while the lowest were in the artery with lightly calcified 
plaque. On the other hand, the highest lumen gain was reported to be in the artery with 
lightly calcified plaque, followed by the arteries with heavily and moderately calcified 
plaques. In comparison, oversizing in a non-calcified artery resulted in a non-linear increase 
in arterial stresses, as well as in the lumen gain. Furthermore, diseased arteries were found 
to be less sensitive to oversizing than healthy arteries due to a smaller increase in the 
arterial stresses between each oversizing ratio. 
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